Clinical trial
Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or…
NCT00005086 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00005086 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer |
| Official title | A Phase II Trial of "Sequential Doublets" Chemotherapy in Patients With Locally Advanced or Metastatic Bladder Cancer |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, docetaxel, gemcitabine hydrochloride, methotrexate |
| Enrollment | 6 |
| Start date | Aug 1, 1999 |
| Primary completion | Aug 1, 2002 |
| Completion | Apr 1, 2005 |
| First posted | May 16, 2003 |
| Last update posted | Sep 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: